Lack of molecular markers to predict malignant potential of oral precancer

Journal of Pathology

Volumn 190, Issue 4, 2000, Pages 407-409

  Warnakulasuriya, Saman ^a,b  

^a Dept of Oral Medicine and Pathology   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Leukoplakia; Oral cancer; Oral precancer; p53; Risk markers

Indexed keywords

PROTEIN P53; TUMOR MARKER;

CANCER RISK; CARCINOGENESIS; GENE OVEREXPRESSION; HUMAN; LEUKOPLAKIA; MOUTH CANCER; PRECANCER; PRIORITY JOURNAL; PROTEIN STABILITY; REVIEW; SQUAMOUS CELL CARCINOMA;

GENETIC MARKERS; HUMANS; LEUKOPLAKIA, ORAL; MOUTH NEOPLASMS; MUTATION; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034098826     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200003)190:4<407::AID-PATH546>3.0.CO;2-D     Document Type: Review

References (18)

1. Axell T, Pindborg JJ, Smith CJ, et al. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. J Oral Pathol Med 1996; 25: 49-54.
2. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous carcinoma. Oral Surg Oral Med Oral Pathol 1995; 79: 321-329.
3. Silverman S Jr, Gorosky M, Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer 1984; 53: 563-568.
4. Karabulut A, Reibel J, Therkildsen MH, et al. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 1995; 24: 198-200.
5. Schepman KP, van der Meij EH, Smeele LE, van der Wall I. Malignant transformation of oral leukoplakia: a follow up study of a hospital-based population of 166 patients with oral leukoplakia from the Netherlands. Oral Oncol 1998; 34: 270-275.
6. Gupta PC, Mehta FS, Daftary DK, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow up study of Indian villagers. Community Dent Oral Epidemiol 1980; 8: 287-333.
7. Shahnavaz SA, Regezi JA, Bradley G, Dubé ID, Jordan RCK. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas. J Pathol 2000; 190: 417-422.
8. Warnakulasuriya S. p53 and oral precancer - a review. In Oral Oncology, Varma AK (ed.), vol 6. McMillan: New Delhi, 1998; 93-96.
9. Murti PR, Warnakulasuriya KAAS, Johnson NW, et al. p53 expression in oral precancer as a marker for malignant potential. J Oral Pathol Med 1998; 27: 191-196.
10. Penhallow J, Steingrimsdottir H, Elamin F, et al. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA. Int J Oncol 1998; 12: 59-68.
11. Atula S, Kurvinen K, Grenman R, Syrjanen S. SSCP pattern indicative for p53 mutation is related to advanced stage and high-grade of tongue cancer. Eur J Cancer B Oral Oncol 1996; 32: 222-229.
12. Save V, Nylander K, Hall PA. Why is p53 protein stabilized in neoplasia? Some answers but many more questions! J Pathol 1998; 184: 348-350.
13. Bottger A, Bottger V, Garcia-Echeverria C, et al. Molecular characterisation of the mdm2 p53 interaction. J Mol Biol 1997; 269: 744-756.
14. Warnakulasuriya KAAS, Tavassoli M, Johnson NW. Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma. J Oral Pathol Med 1998; 27: 367-381.
15. Warnakulasuriya KAAS, Johnson NW. Importance of cell proliferation markers in oral pathology. In Current Topics in Pathology, Seifert G (ed.), vol 90. Springer-Verlag: Berlin, 1996; 147-177.
16. Dictor M, Ehinger M, Mertens F, Akervall J, Wennerberg J. Abnormal cell cycle regulation in malignancy. Am J Clin Pathol 1999; 112 (Suppl 1) S40-S52.
17. Sartor M, Steingrimsdottir H, Elamin F, et al. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Br J Cancer 1999; 80: 79-86.
18. Partridge M, Kiguwa S, Emilion G, Pateromichelakis S, Hern RA, Langdon JD. New insights into p53 protein stabilization in oral squamous cell carcinoma. Eur J Cancer B Oral Oncol 1999; 35: 45-55.